This is a protocol for a Cochrane Review (Intervention). The objectives are as follows:

To determine the benefits and harms of angiogenesis inhibitors in the treatment of lung cancer when given alone, following or in combination with chemotherapy or chemo‐radiotherapy (in the case of locally advanced non‐metastatic NSCLC or limited stage SCLC).